Animal

Santhera and ReveraGen to Present Phase 2a/2b Efficacy and New Safety Data with Vamorolone at Forthcoming Conferences

Thursday, September 23, 2021 - 6:05am

Recently, Santhera and ReveraGen announced statistically highly significant and clinically relevant data from the pivotal Phase 2b VISION-DMD study in patients with Duchenne muscular dystrophy (DMD) [1-3].

Key Points: 
  • Recently, Santhera and ReveraGen announced statistically highly significant and clinically relevant data from the pivotal Phase 2b VISION-DMD study in patients with Duchenne muscular dystrophy (DMD) [1-3].
  • The efficacy data confirm earlier results from a Phase 2a long-term extension trial, where vamorolone demonstrated similar efficacy to corticoid-treated DMD-patients after 30 months of treatment [4].
  • Based on clinical trial results, including long-term safety data up to 30 months, vamorolone at doses up to 6 mg/kg/day was generally well-tolerated.
  • The study also demonstrated superiority of both vamorolone dose levels (2 and 6mg/kg/day) versus placebo across multiple secondary endpoints.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AdaptHealth, Koninklijke Philips, PayPal, and Boston Beer and Encourages Investors to Contact the Firm

Thursday, September 23, 2021 - 2:31am

On this news, AdaptHealths stock price fell$1.51per share, or 5.93%, to close at$23.96per share onJuly 19, 2021.

Key Points: 
  • On this news, AdaptHealths stock price fell$1.51per share, or 5.93%, to close at$23.96per share onJuly 19, 2021.
  • On this news,Philips stock price fell $2.25 per share, or 3.98%, to close at $54.25 per share on June 14, 2021.
  • Throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and compliance policies.
  • For more information on the Boston Beer class action go to: https://bespc.com/cases/SAM
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Yalla, Sesen Bio, and loanDepot and Encourages Investors to Contact the Firm

Thursday, September 23, 2021 - 2:18am

On May 19, 2021, Swan Street Research (Swan Street) published a report (the Swan Street Report) addressingYalla, entitled IsYallaGroup a Multi $B Fraud?

Key Points: 
  • On May 19, 2021, Swan Street Research (Swan Street) published a report (the Swan Street Report) addressingYalla, entitled IsYallaGroup a Multi $B Fraud?
  • On this news, the price ofYallashares fell $1.31 per share, or 7.15%, to close at $17.01 per share on May 19, 2021.
  • The next day, May 20, 2021, analyst The Bear Cave issued a report entitled, "Problems atYallaGroup," and Gotham City Research also tweeted that it was shortingYallashares.
  • For more information on the loanDepot class action go to: https://bespc.com/cases/LDI
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Zymergen, Annovis Bio, and Cassava Sciences and Encourages Investors to Contact the Firm

Thursday, September 23, 2021 - 2:08am

In April 2021, Zymergen completed its IPO, selling approximately 18.5 million shares of common stock at $31 per share.

Key Points: 
  • In April 2021, Zymergen completed its IPO, selling approximately 18.5 million shares of common stock at $31 per share.
  • As a result, Zymergen no longer expects product revenue in 2021, and expects product revenue to be immaterial in 2022.
  • For more information on the Zymergen class action go to: https://bespc.com/cases/ZY
    On July 28, 2021, after the market closed,Annovisreported interim clinical data from its Phase 2a trial.
  • For more information on the Cassava Sciences class action go to: https://bespc.com/cases/SAVA
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ardelyx, SelectQuote, Katapult, and Waterdrop Sciences and Encourages Investors to Contact the Firm

Thursday, September 23, 2021 - 2:08am

On this news, the Companys share price declined, falling $9.71 per share, or nearly 74%, to close at $2.01 per share on July 20, 2021.

Key Points: 
  • On this news, the Companys share price declined, falling $9.71 per share, or nearly 74%, to close at $2.01 per share on July 20, 2021.
  • Furthermore, Waterdrop had suffered rapidly accelerating operating losses in the first quarter of 2021 which was completed weeksbeforethe IPO.
  • For more information on the Waterdrop class action go to: https://bespc.com/cases/WDH
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Iterum, View, and Spectrum and Encourages Investors to Contact the Firm

Thursday, September 23, 2021 - 2:07am

On this news, Iterums ordinary share price fell $0.87 per share, or 37.99%, to close at $1.42 per share on July 2, 2021.

Key Points: 
  • On this news, Iterums ordinary share price fell $0.87 per share, or 37.99%, to close at $1.42 per share on July 2, 2021.
  • On this news, Iterums ordinary share price fell $0.499 per share, or 44.16%, to close at $0.631 per share on July 26, 2021.
  • For more information on the Spectrum class action go to: https://bespc.com/cases/SPPI
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Concho, ATI, HyreCar, and The Honest Company and Encourages Investors to Contact the Firm

Thursday, September 23, 2021 - 2:03am

On July 31, 2019, after the close of trading, Concho released its financial results for the second quarter 2019.

Key Points: 
  • On July 31, 2019, after the close of trading, Concho released its financial results for the second quarter 2019.
  • ThoughATIwas implementing certain remedial actions, the Company reduced its fiscal 2021 forecast due to the foregoing factors.
  • Honest Company also disclosed that its Diapers and Wipes category revenue declined 2% compared to the second quarter of 2020.
  • For more information on the Honest Company class action go to: https://bespc.com/cases/HNST
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Live Ventures, Generac, and Longeveron and Encourages Investors to Contact the Firm

Thursday, September 23, 2021 - 2:02am

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points: 
  • Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
  • On this news, the Companys share price fell $29.08, or 46%, to close at $33.50 per share on August 4, 2021, on unusually heavy trading volume.
  • For more information on the Longeveron class action go to: https://bespc.com/cases/LGVN
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Oatly Group AB and Encourages Investors to Contact the Firm

Thursday, September 23, 2021 - 2:09am

Investors have until September 24, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until September 24, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • On July 14, 2021, before the market opened, short seller Spruce Point issued a Report entitled, Sour on an Oat-lier Investment.
  • The action alleges that Oatly and the other defendants made materially false and/or misleading statement to investors during the Class Period.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

SAM EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces That a Securities Fraud Class Action Lawsuit Was Filed on Behalf of Investors of the Boston Beer Company, Inc.

Thursday, September 23, 2021 - 1:21am

Deadline Reminder: Investors who purchased or acquired Boston Beer securities during the Class Period may, no later than November 15, 2021, seek to be appointed as a lead plaintiff representative of the class.

Key Points: 
  • Deadline Reminder: Investors who purchased or acquired Boston Beer securities during the Class Period may, no later than November 15, 2021, seek to be appointed as a lead plaintiff representative of the class.
  • For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq.
  • The Class Period commences on April 22, 2021, when Boston Beer announced its first quarter 2021 financial results.
  • The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.